Contrave
- Product NDC
- 43063-772
- 11-digit product format
- 430630772
- Labeler code
- 43063
- Product ID
- 43063-772_dea9a508-9ae4-9a58-e053-2a95a90a967f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- naltrexone hydrochloride and bupropion hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- NDA200063
- Marketing category
- NDA
- Marketing start
- 2014-10-22
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
- Active strength
- 90 mg/1; mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA], Opioid Antagonist [EPC], Opioid Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43063-772-70 | 43063077270 | 70 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43063-772-70) | 2017-06-16 | 0000-00-00 | No | No | Current |